News
It can be a very powerful system. [jephthal] took the excellent Mecrisp Forth and put it on the very inexpensive STM32 “blue pill” board to create a development system that cost about $2.
Andrew J. Oakley, Chairman of the Board of Onconetix, stated, “We are excited about the opportunity to combine forces with Ocuvex, whose pipeline of commercial and late clinical stage ophthalmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results